Document is current

Article History

Received: 26 May 2026

Accepted: 16 August 2026

First Online: 28 August 2026

Declarations

Conflict of interest: TH and JR are employed by Takeda. KG is employed by AbbVie. AB is employed by GSK. Each of these authors owns stock in their respective employer. GT and AB are Editorial Board members of Drug Safety . GT and AB were not involved in the selection of peer reviewers for the manuscript nor in any of the subsequent editorial decisions. No other competing interests to declare.

Ethics Approval: Not applicable. The article does not involve human subjects research, patient data, or clinical interventions.

Consent to Participate: Not applicable.

Consent for Publication: Not applicable.

Availability of Data and Material: Data sharing is not applicable to this article because no datasets were generated or analyzed for this paper. All information supporting the arguments in this article is contained within the paper and its references.

Code Availability: Not applicable.

Author Contributions: TH conceived the manuscript. All authors contributed to the writing, revision, and editing of the manuscript and approved the final version.

Disclaimer: The views expressed in this publication are solely those of the authors and do not necessarily represent the views of, or imply endorsement by, their employer.